RSLS

ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders

ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds

Here's Why ReShape Life Sciences Has An Opportunity To See A Big Short Squeeze

RSLS Stock Price Increases Over 20% Pre-Market: Why It Happened

4 Biotech and Life Sciences Stocks Trading Under $10 With Gigantic Upside Potential

ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market